<SEC-DOCUMENT>0000318154-21-000005.txt : 20210202
<SEC-HEADER>0000318154-21-000005.hdr.sgml : 20210202
<ACCEPTANCE-DATETIME>20210202161308
ACCESSION NUMBER:		0000318154-21-000005
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210202
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210202
DATE AS OF CHANGE:		20210202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMGEN INC
		CENTRAL INDEX KEY:			0000318154
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				953540776
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37702
		FILM NUMBER:		21581598

	BUSINESS ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320
		BUSINESS PHONE:		(805)447-1000

	MAIL ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMGEN
		DATE OF NAME CHANGE:	19870305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>amgn-20210202.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:61d6a7ca-8073-494f-b5f4-2e4c02ab1cef,g:6a34a050-e988-4858-b9db-b0e2193630c9,d:f27981d0ab0343c1ba8c6a79752c2885--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amgn="http://www.amgen.com/20210202" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>amgn-20210202</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i449116e6ef614a8a879a88c45e141e6b_D20210202-20210202" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmYyNzk4MWQwYWIwMzQzYzFiYThjNmE3OTc1MmMyODg1L3NlYzpmMjc5ODFkMGFiMDM0M2MxYmE4YzZhNzk3NTJjMjg4NV80L2ZyYWc6ZjdiYzlhOTdlOTA2NDgyYmIwNGYzNmEzZGYyODA2NjQvdGFibGU6M2Q4YWZjZGRkNDg0NGVkZmExYTEyNjk5ZDM3ZmU0MDMvdGFibGVyYW5nZTozZDhhZmNkZGQ0ODQ0ZWRmYTFhMTI2OTlkMzdmZTQwM18zLTEtMS0xLTA_48142efb-729b-4686-8e51-86dd09f35170">0000318154</ix:nonNumeric><ix:nonNumeric contextRef="i449116e6ef614a8a879a88c45e141e6b_D20210202-20210202" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmYyNzk4MWQwYWIwMzQzYzFiYThjNmE3OTc1MmMyODg1L3NlYzpmMjc5ODFkMGFiMDM0M2MxYmE4YzZhNzk3NTJjMjg4NV80L2ZyYWc6ZjdiYzlhOTdlOTA2NDgyYmIwNGYzNmEzZGYyODA2NjQvdGFibGU6M2Q4YWZjZGRkNDg0NGVkZmExYTEyNjk5ZDM3ZmU0MDMvdGFibGVyYW5nZTozZDhhZmNkZGQ0ODQ0ZWRmYTFhMTI2OTlkMzdmZTQwM180LTEtMS0xLTA_73ea2212-27e9-4a9b-b590-c3ff728eaafb">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="amgn-20210202.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i449116e6ef614a8a879a88c45e141e6b_D20210202-20210202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-02</xbrli:startDate><xbrli:endDate>2021-02-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8976664852c4d799029775bd6fcfbdd_D20210202-20210202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNGS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-02</xbrli:startDate><xbrli:endDate>2021-02-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7330a2ead30f4ef5a000dce8fd6ba44f_D20210202-20210202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A1.250SeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-02</xbrli:startDate><xbrli:endDate>2021-02-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i504de6d1e4f4436aa3250ce36753b508_D20210202-20210202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A2.00SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-02</xbrli:startDate><xbrli:endDate>2021-02-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if27981d0ab0343c1ba8c6a79752c2885_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;text-indent:22.5pt"><span><br/></span></div></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:1.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i449116e6ef614a8a879a88c45e141e6b_D20210202-20210202" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmYyNzk4MWQwYWIwMzQzYzFiYThjNmE3OTc1MmMyODg1L3NlYzpmMjc5ODFkMGFiMDM0M2MxYmE4YzZhNzk3NTJjMjg4NV8xL2ZyYWc6MzVmY2UxN2E0OWM5NGVhZThhYzU4MjQyMzM3MzY2YzEvdGV4dHJlZ2lvbjozNWZjZTE3YTQ5Yzk0ZWFlOGFjNTgyNDIzMzczNjZjMV8xMTIy_c6e0d117-9552-418f-8b5c-5734b130ae19">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:1.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 OR 15(d) of</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i449116e6ef614a8a879a88c45e141e6b_D20210202-20210202" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmYyNzk4MWQwYWIwMzQzYzFiYThjNmE3OTc1MmMyODg1L3NlYzpmMjc5ODFkMGFiMDM0M2MxYmE4YzZhNzk3NTJjMjg4NV8xL2ZyYWc6MzVmY2UxN2E0OWM5NGVhZThhYzU4MjQyMzM3MzY2YzEvdGV4dHJlZ2lvbjozNWZjZTE3YTQ5Yzk0ZWFlOGFjNTgyNDIzMzczNjZjMV8yMjg_50b08831-9199-4848-b851-e22ba803ea41">February 2, 2021</ix:nonNumeric> </span></div><div style="margin-bottom:1.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i449116e6ef614a8a879a88c45e141e6b_D20210202-20210202" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmYyNzk4MWQwYWIwMzQzYzFiYThjNmE3OTc1MmMyODg1L3NlYzpmMjc5ODFkMGFiMDM0M2MxYmE4YzZhNzk3NTJjMjg4NV8xL2ZyYWc6MzVmY2UxN2E0OWM5NGVhZThhYzU4MjQyMzM3MzY2YzEvdGV4dHJlZ2lvbjozNWZjZTE3YTQ5Yzk0ZWFlOGFjNTgyNDIzMzczNjZjMV8xMTIz_acc3b3be-e15f-4120-8a2a-0d5f260e7fe6">Amgen Inc.</ix:nonNumeric> </span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%